Breaking News Instant updates and real-time market news.

NVCN

Neovasc

$1.52

0.01 (0.66%)

, EW

Edwards Lifesciences

$114.60

-0.35 (-0.30%)

10:46
06/16/17
06/16
10:46
06/16/17
10:46

Neovasc: German court partially finds in favor of Edwards Lifesciences in suit

Neovasc (NVCN) reported that the District Court in Munich, Germany has partially found in favor of Edwards Lifesciences Corporation (EW), in its case against Neovasc. In this case, CardiAQ had claimed ownership rights to one of Neovasc's European patent applications for its Tiara mitral valve replacement technology. The German court found CardiAQ had contributed in part to the invention of the Tiara and awarded to CardiAQ co-entitlement rights to the disputed Tiara European patent application. There are no monetary awards associated with this matter. Neovasc intends to appeal this decision. In a related matter, Neovasc is currently appealing the 2016 decision from the U.S District Court for the District of Massachusetts which among other things granted co-inventorship rights to CardiAQ on one of Neovasc's granted U.S. patent applications. This appeal is now before the United States Court of Appeals for the Federal Circuit in Washington D.C. An expedited appeal schedule has been set with all the briefings from both parties now submitted. The Company expects oral argument on its appeal in August 2017 and a ruling is expected to follow, prior to the end of 2017. Pending the outcome of the U.S. Court of Appeals, Neovasc, in consultation with its European and North American legal advisors, will vigorously defend its position that the case in Germany is without merit and will explore all options regarding the appellate process.

NVCN

Neovasc

$1.52

0.01 (0.66%)

EW

Edwards Lifesciences

$114.60

-0.35 (-0.30%)

  • 20

    Jun

  • 15

    Aug

NVCN Neovasc
$1.52

0.01 (0.66%)

04/05/17
LTCO
04/05/17
UPGRADE
Target $4
LTCO
Buy
Neovasc upgraded to Buy on Reducer and Tiara advancement at Ladenburg
As previously reported, Ladenburg analyst Jeffrey Cohen upgraded Neovasc to Buy from Neutral with a $4 price target. The analyst told investors he is encouraged by Reducer update combined with Tiara's pace of clinical work. He expects current litigation will conclude in 2H 2017 and that the current scenario of decision/liabilities represents a worse case scenario with potential upside from a reversal of decisions and/or liabilities.
04/05/17
LTCO
04/05/17
UPGRADE
LTCO
Buy
Neovasc upgraded to Buy from Neutral at Ladenburg
12/02/16
LEER
12/02/16
NO CHANGE
LEER
Outperform
Neovasc's Boston Scientific deal provides a reprieve, says Leerink
Leerink analyst Danielle Antalffy said Neovasc (NVCN) share are reacting positively to the announcement that Boston Scientific (BSX) is aquiring tissue manufacturing assets and a 15% stake on the company for $75M. The analyst said the deal significantly improves its ability to continue to operate regardless of the outcome of ongoing litigation and believes the likelihood that Neovasc can continue to operate has increased substantially. Antalffy rates Neovasc an Outperform.
EW Edwards Lifesciences
$114.60

-0.35 (-0.30%)

05/26/17
BOFA
05/26/17
NO CHANGE
Target $140
BOFA
Buy
Edwards Lifesciences price target raised to $140 from $120 at BofA/Merrill
BofA/Merrill analyst Bob Hopkins raised best large cap idea Edwards Lifescience's price target to $140 from $120 and reiterated his Buy rating The analyst thinks the Street is underestimating the strength in the US TAVR market and said 3-year average trend growth is the highest in years. Hopkins is also bullish on the new Ultra delivery system following favorable physician feedback.
05/23/17
MSCO
05/23/17
NO CHANGE
MSCO
Medtech Technology sector upgraded to Attractive from In-Line at Morgan Stanley
Morgan Stanley upgraded the Medtech Technology sector to Attractive saying structural fundamentals have improved and recent acceleration will likely continue, driving further multiple expansion.
05/17/17
RHCO
05/17/17
NO CHANGE
RHCO
Edwards Lifesciences data 'very strong, ' says SunTrust
SunTrust analyst Bruce Nudell says that the data presented on Edwards' self-expanding Centera valve was "very strong." The analyst thinks the company has a good chance to increase its market share in the category over time. He raised his price target on the stock to $130 from $120 and keeps a Buy rating.
05/17/17
ADAM
05/17/17
NO CHANGE
Target $150
ADAM
Buy
Edwards Lifesciences reiterated as a top large-cap pick at Canaccord
Canaccord analyst Jason Mills reiterated Edwards Lifesciences as a top large-cap pick, citing the robust clinical data on Centara presented at the EuroPCR, which reinforced his bullish thesis regarding the company's leadership in the most dynamic contemporary market in all of Med-Tech. Mills reiterated his Buy rating and raised his price target to $150 from $140 on Edwards Lifesciences shares.

TODAY'S FREE FLY STORIES

08:05
06/22/17
06/22
08:05
06/22/17
08:05
General news
Treasury Market Outlook: bonds are little changed »

Treasury Market Outlook:…

WFM

Whole Foods

$43.26

0.48 (1.12%)

, KR

Kroger

$22.37

-0.01 (-0.04%)

08:04
06/22/17
06/22
08:04
06/22/17
08:04
Recommendations
Whole Foods, Kroger, Costco, Target, Wal-Mart, Amazon.com analyst commentary  »

JPMorgan has 'hard…

WFM

Whole Foods

$43.26

0.48 (1.12%)

KR

Kroger

$22.37

-0.01 (-0.04%)

COST

Costco

$163.15

0.25 (0.15%)

TGT

Target

$50.52

-0.39 (-0.77%)

WMT

Wal-Mart

$76.24

0.7 (0.93%)

AMZN

Amazon.com

$1,002.23

9.64 (0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 28

    Jun

  • 23

    Aug

ISBC

Investors Bancorp

$13.08

-0.18 (-1.36%)

08:04
06/22/17
06/22
08:04
06/22/17
08:04
Hot Stocks
Investors Bancorp appoints Michael Fegan Chief Information and Operations Office »

Investors Bank has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JW.A

John Wiley

$51.75

0.4 (0.78%)

, JW.B

08:04
06/22/17
06/22
08:04
06/22/17
08:04
Hot Stocks
John Wiley & Sons raises quarterly dividend 3% to 32c per share »

John Wiley & Sons…

JW.A

John Wiley

$51.75

0.4 (0.78%)

JW.B

JWB

John Wiley & Sons; also tag JWA

JWA

John Wiley & Sons; also tag JWB

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AME

Ametek

$60.51

-1.36 (-2.20%)

, MOCO

Mocon

08:04
06/22/17
06/22
08:04
06/22/17
08:04
Hot Stocks
Ametek completes acquisition of Mocon »

Ametek (AME) announced…

AME

Ametek

$60.51

-1.36 (-2.20%)

MOCO

Mocon

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSE

Trinseo

$65.05

-0.5 (-0.76%)

08:03
06/22/17
06/22
08:03
06/22/17
08:03
Hot Stocks
Trinseo increases quarterly dividend, announces new share repurchase program »

Trinseo announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TROV

Trovagene

$0.95

0.0471 (5.24%)

08:02
06/22/17
06/22
08:02
06/22/17
08:02
Hot Stocks
Trovagene to provide Trovera tests and services for global pharma company »

Trovagene has entered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAIN

Hain Celestial

$33.16

0.13 (0.39%)

08:02
06/22/17
06/22
08:02
06/22/17
08:02
Technical Analysis
Technical View: Hain Celestial up after earnings, buybacks, new CFO »

The shares were last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 27

    Jun

TSLA

Tesla

$376.40

4.16 (1.12%)

08:01
06/22/17
06/22
08:01
06/22/17
08:01
Periodicals
Tianjin not participating in Tesla's China project at this time, Reuters says »

Tianjin Motors says it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

MNK

Mallinckrodt

$45.37

2.06 (4.76%)

08:00
06/22/17
06/22
08:00
06/22/17
08:00
Options
Mallinckrodt call buyer realizes 74% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:00
06/22/17
06/22
08:00
06/22/17
08:00
General news
Breaking General news story  »

New York Federal Reserve…

ORCL

Oracle

$46.33

0.49 (1.07%)

07:59
06/22/17
06/22
07:59
06/22/17
07:59
Upgrade
Oracle rating change  »

Oracle upgraded on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

BRK.A

Berkshire Hathaway

$254,400.00

-1460 (-0.57%)

, BRK.B

Berkshire Hathaway

$169.62

-0.93 (-0.55%)

07:57
06/22/17
06/22
07:57
06/22/17
07:57
Hot Stocks
Berkshire to invest up to C$400M in Home Capital, provide C$2B line of credit »

Canada's Home…

BRK.A

Berkshire Hathaway

$254,400.00

-1460 (-0.57%)

BRK.B

Berkshire Hathaway

$169.62

-0.93 (-0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCD

McDonald's

$153.73

-0.34 (-0.22%)

, AMZN

Amazon.com

$1,002.23

9.64 (0.97%)

07:56
06/22/17
06/22
07:56
06/22/17
07:56
Periodicals
McDonald's teams up with UberEats in Britain, Engadget reports »

McDonald's (MCD) is…

MCD

McDonald's

$153.73

-0.34 (-0.22%)

AMZN

Amazon.com

$1,002.23

9.64 (0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

KMDA

Kamada

$7.50

-0.05 (-0.66%)

07:55
06/22/17
06/22
07:55
06/22/17
07:55
Technical Analysis
Technical View: Kamada dives after withdrawing MAA for AAT therapy with EMA »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

NEP

NextEra Energy Partners

$35.11

0.03 (0.09%)

, NEE

NextEra Energy

$141.06

-0.9 (-0.63%)

07:55
06/22/17
06/22
07:55
06/22/17
07:55
Conference/Events
NextEra Energy and NextEra Energy Partners to hold an investor meeting »

Investor Meeting to be…

NEP

NextEra Energy Partners

$35.11

0.03 (0.09%)

NEE

NextEra Energy

$141.06

-0.9 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 22

    Jun

LLY

Eli Lilly

$82.64

-0.11 (-0.13%)

07:55
06/22/17
06/22
07:55
06/22/17
07:55
Conference/Events
FDA Pediatric Oncology Subcommittee of Oncologic Drugs Committee holds a meeting »

The Pediatric Oncology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

SPLS

Staples

$8.66

-0.09 (-1.03%)

07:52
06/22/17
06/22
07:52
06/22/17
07:52
Recommendations
Staples analyst commentary  »

Staples LBO could work in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSM

TSMC

$36.71

0.58 (1.61%)

, QCOM

Qualcomm

$56.33

-0.46 (-0.81%)

07:51
06/22/17
06/22
07:51
06/22/17
07:51
Periodicals
TSMC receives 7nm chip orders from Qualcomm, DigiTimes reports »

TSMC (TSM) has secured…

TSM

TSMC

$36.71

0.58 (1.61%)

QCOM

Qualcomm

$56.33

-0.46 (-0.81%)

SSNLF

Samsung

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OTIC

Otonomy

$17.50

1.45 (9.03%)

07:50
06/22/17
06/22
07:50
06/22/17
07:50
Hot Stocks
Otonomy announces successful end-of-Phase 2 review by FDA for Otiprio »

Otonomy announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCS

Steelcase

$16.30

-0.2 (-1.21%)

07:50
06/22/17
06/22
07:50
06/22/17
07:50
Technical Analysis
Technical View: Steelcase drops sharply after earnings and outlook »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

TRGP

Targa Resources

$40.68

-0.73 (-1.76%)

07:49
06/22/17
06/22
07:49
06/22/17
07:49
Recommendations
Targa Resources analyst commentary  »

Targa Resources guidance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:47
06/22/17
06/22
07:47
06/22/17
07:47
General news
Futures slightly higher ahead of claims data »

Stock futures are trading…

DHI

D.R. Horton

$33.97

-0.2 (-0.59%)

, FOR

Forestar Group

$16.30

-0.1 (-0.61%)

07:45
06/22/17
06/22
07:45
06/22/17
07:45
Hot Stocks
D.R. Horton reiterates proposal to acquire 75% of Forestar Group »

D.R. Horton (DHI) said…

DHI

D.R. Horton

$33.97

-0.2 (-0.59%)

FOR

Forestar Group

$16.30

-0.1 (-0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPC

Edgewell Personal Care

$75.05

-0.67 (-0.88%)

07:45
06/22/17
06/22
07:45
06/22/17
07:45
Upgrade
Edgewell Personal Care rating change  »

Edgewell Personal Care…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.